Transformative Technologies: How CEO Clubs Members are Shaping the Future

Dubai, July 23, 2024 – The CEO Clubs hosted an engaging and informative virtual meeting titled “Transforming Healthcare Device for Cancer with TransMed7” on July 23rd via Zoom. This event centered on unveiling groundbreaking investment opportunities in advanced biopsy medical devices designed for breast and prostate cancer.

The meeting commenced with a warm welcome from Ms. Sarah Dong, Managing Partner of CEO Clubs, who expressed deep appreciation for their valued member, Dr. William Wraith III, Co-Founder & Chairman Emeritus of Lyten, Inc. Dr. Wraith, a distinguished Silicon Valley entrepreneur and philanthropist, has a remarkable career spanning over four decades. His contributions to global resource management and transformative philanthropic endeavors were instrumental in enriching the meeting’s discussions. The meeting has gathered nearly 20 attendees including CEO Clubs valued members Dr. Aftab Hasan, Chairman, Risk Exchange (DIFC) Limited, Mr. NavoditMehra, Managing Partner & General Counsel, Confity Capital Partners, Mr. ShabbirRajaraliVakil, Chairman, Al Vakil Group.

The highlight of the session was Dr. James Vetter, Founder, CEO, and Chairman of TransMed7, who presented the company’s mission to revolutionize the treatment of life-threatening diseases like cancer and heart disease. Dr. Vetter provided a detailed overview of TransMed7’s latest disruptive technologies, including their innovative biopsy medical devices that aim to transform diagnostics and treatment protocols. His presentation underscored the company’s commitment to reducing the duration of breast biopsies from 30 minutes to 5 minutes, ensuring ease of operation, and minimizing bleeding and trauma through cutting-edge technology.

“TransMed7 is actively seeking investors for its productions, enhancing its sales force, and expanding global distribution. We are proud of our valued member for developing such a disruptive solution that saves lives. We will facilitate and connect with TransMed7 to explore these investment opportunities through the CEO Clubs Network,” saidMrs. Sarah Dong.

Dr. Tariq, CEO of CEO Clubs Network passionately stated “Thank you all for your active participation and insightful contributions. Today’s discussions have not only highlighted the transformative potential of these groundbreaking healthcare technologies but have also underscored the power of collaboration and innovation. Together, we are paving the way for a future where life-threatening diseases can be managed more effectively, significantly improving the quality of life for countless individuals. Let us continue to harness our collective expertise and drive impactful change, ensuring that these advancements reach those who need them most. Our journey toward revolutionizing healthcare has just begun, and I am confident that, with your support and dedication, we will achieve remarkable success”.